99 related articles for article (PubMed ID: 19182994)
1. Ha-ras oncogene-induced Stat3 phosphorylation enhances oncogenicity of the cell.
Yeh HH; Giri R; Chang TY; Chou CY; Su WC; Liu HS
DNA Cell Biol; 2009 Mar; 28(3):131-9. PubMed ID: 19182994
[TBL] [Abstract][Full Text] [Related]
2. Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3.
Leslie K; Lang C; Devgan G; Azare J; Berishaj M; Gerald W; Kim YB; Paz K; Darnell JE; Albanese C; Sakamaki T; Pestell R; Bromberg J
Cancer Res; 2006 Mar; 66(5):2544-52. PubMed ID: 16510571
[TBL] [Abstract][Full Text] [Related]
3. Serine 727 phosphorylation of STAT3: an early change in mouse hepatocarcinogenesis induced by neonatal treatment with diethylnitrosamine.
Miyakoshi M; Yamamoto M; Tanaka H; Ogawa K
Mol Carcinog; 2014 Jan; 53(1):67-76. PubMed ID: 22911886
[TBL] [Abstract][Full Text] [Related]
4. Reduced phosphorylation of Stat3 at Ser-727 mediated by casein kinase 2 - protein phosphatase 2A enhances Stat3 Tyr-705 induced tumorigenic potential of glioma cells.
Mandal T; Bhowmik A; Chatterjee A; Chatterjee U; Chatterjee S; Ghosh MK
Cell Signal; 2014 Aug; 26(8):1725-34. PubMed ID: 24726840
[TBL] [Abstract][Full Text] [Related]
5. Ras induces experimental lung metastasis through up-regulation of RbAp46 to suppress RECK promoter activity.
Yeh HH; Tseng YF; Hsu YC; Lan SH; Wu SY; Raghavaraju G; Cheng DE; Lee YR; Chang TY; Chow NH; Hung WC; Liu HS
BMC Cancer; 2015 Mar; 15():172. PubMed ID: 25885317
[TBL] [Abstract][Full Text] [Related]
6. Hdac7 promotes lung tumorigenesis by inhibiting Stat3 activation.
Lei Y; Liu L; Zhang S; Guo S; Li X; Wang J; Su B; Fang Y; Chen X; Ke H; Tao W
Mol Cancer; 2017 Nov; 16(1):170. PubMed ID: 29126425
[TBL] [Abstract][Full Text] [Related]
7. Differential interleukin-6/Stat3 signaling as a function of cellular context mediates Ras-induced transformation.
Leslie K; Gao SP; Berishaj M; Podsypanina K; Ho H; Ivashkiv L; Bromberg J
Breast Cancer Res; 2010; 12(5):R80. PubMed ID: 20929542
[TBL] [Abstract][Full Text] [Related]
8. Antisense DNA inhibition of tumor growth induced by c-Ha-ras oncogene in nude mice.
Gray GD; Hernandez OM; Hebel D; Root M; Pow-Sang JM; Wickstrom E
Cancer Res; 1993 Feb; 53(3):577-80. PubMed ID: 8425190
[TBL] [Abstract][Full Text] [Related]
9. CADPE suppresses cyclin D1 expression in hepatocellular carcinoma by blocking IL-6-induced STAT3 activation.
Won C; Lee CS; Lee JK; Kim TJ; Lee KH; Yang YM; Kim YN; Ye SK; Chung MH
Anticancer Res; 2010 Feb; 30(2):481-8. PubMed ID: 20332458
[TBL] [Abstract][Full Text] [Related]
10. Activation of signal transducer and activator of transcription 3 through a phosphomimetic serine 727 promotes prostate tumorigenesis independent of tyrosine 705 phosphorylation.
Qin HR; Kim HJ; Kim JY; Hurt EM; Klarmann GJ; Kawasaki BT; Duhagon Serrat MA; Farrar WL
Cancer Res; 2008 Oct; 68(19):7736-41. PubMed ID: 18829527
[TBL] [Abstract][Full Text] [Related]
11. Tyr23 phosphorylation of Anxa2 enhances STAT3 activation and promotes proliferation and invasion of breast cancer cells.
Yuan J; Yang Y; Gao Z; Wang Z; Ji W; Song W; Zhang F; Niu R
Breast Cancer Res Treat; 2017 Jul; 164(2):327-340. PubMed ID: 28470457
[TBL] [Abstract][Full Text] [Related]
12. Ras/ERK1/2-mediated STAT3 Ser727 phosphorylation by familial medullary thyroid carcinoma-associated RET mutants induces full activation of STAT3 and is required for c-fos promoter activation, cell mitogenicity, and transformation.
Plaza-Menacho I; van der Sluis T; Hollema H; Gimm O; Buys CH; Magee AI; Isacke CM; Hofstra RM; Eggen BJ
J Biol Chem; 2007 Mar; 282(9):6415-24. PubMed ID: 17209045
[TBL] [Abstract][Full Text] [Related]
13. Hyperactivation of Ha-ras oncogene, but not Ink4a/Arf deficiency, triggers bladder tumorigenesis.
Mo L; Zheng X; Huang HY; Shapiro E; Lepor H; Cordon-Cardo C; Sun TT; Wu XR
J Clin Invest; 2007 Feb; 117(2):314-25. PubMed ID: 17256055
[TBL] [Abstract][Full Text] [Related]
14. Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells.
Sato M; Vaughan MB; Girard L; Peyton M; Lee W; Shames DS; Ramirez RD; Sunaga N; Gazdar AF; Shay JW; Minna JD
Cancer Res; 2006 Feb; 66(4):2116-28. PubMed ID: 16489012
[TBL] [Abstract][Full Text] [Related]
15. Cyclin D1 overexpression and response to bortezomib treatment in a breast cancer model.
Ishii Y; Pirkmaier A; Alvarez JV; Frank DA; Keselman I; Logothetis D; Mandeli J; O'Connell MJ; Waxman S; Germain D
J Natl Cancer Inst; 2006 Sep; 98(17):1238-47. PubMed ID: 16954476
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-6 Prevents the Initiation but Enhances the Progression of Lung Cancer.
Qu Z; Sun F; Zhou J; Li L; Shapiro SD; Xiao G
Cancer Res; 2015 Aug; 75(16):3209-15. PubMed ID: 26122841
[TBL] [Abstract][Full Text] [Related]
17. Macrophages promote benzopyrene-induced tumor transformation of human bronchial epithelial cells by activation of NF-κB and STAT3 signaling in a bionic airway chip culture and in animal models.
Li E; Xu Z; Zhao H; Sun Z; Wang L; Guo Z; Zhao Y; Gao Z; Wang Q
Oncotarget; 2015 Apr; 6(11):8900-13. PubMed ID: 25823926
[TBL] [Abstract][Full Text] [Related]
18. Effect of Ha-rasval12 on nm23 expression, tumor formation and metastasis of the transformants, and immunomodulation in tumor-bearing mice.
Hsieh CC; Wu SY; Lan SH; Weng TY; Tsai Y; Liu HS
Anticancer Res; 2010 Sep; 30(9):3585-92. PubMed ID: 20944141
[TBL] [Abstract][Full Text] [Related]
19. An RNA-binding protein alphaCP-1 is involved in the STAT3-mediated suppression of NF-kappaB transcriptional activity.
Nishinakamura H; Minoda Y; Saeki K; Koga K; Takaesu G; Onodera M; Yoshimura A; Kobayashi T
Int Immunol; 2007 May; 19(5):609-19. PubMed ID: 17383969
[TBL] [Abstract][Full Text] [Related]
20. Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells.
Zhang Y; Du XL; Wang CJ; Lin DC; Ruan X; Feng YB; Huo YQ; Peng H; Cui JL; Zhang TT; Wang YQ; Zhang H; Zhan QM; Wang MR
Gastroenterology; 2012 Mar; 142(3):521-530.e3. PubMed ID: 22108192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
